The reactivity of [rac-(C2H4(1-indenyl)2)Zr(n-butyl)][MeB(C6F5)3] (4), [rac-(C2H4(1-indenyl)2)Zr(sec-butyl)][MeB(C6F5)3] (5), and [rac-(C2H4(1-indenyl)2)Zr(polypropenyl)][MeB(C6F5)3] with propene, ethene, and hydrogen was studied by low-temperature (<-40 degrees C) 1H and 13C NMR spectroscopy in toluene solutions. In contrast with previous suggestions that 2 degrees zirconium alkyl species such as 5 are dormant sites, these measurements demonstrate reactivity of 2 degrees zirconium alkyls with propene and ethene comparable to the 1 degrees zirconium alkyl species 4 and [rac-(C2H4(1-indenyl)2)Zr(polypropenyl)][MeB(C6F5)3]. Because 2,1-insertion of propene is an infrequent event, these results preclude significant accumulation of catalyst in the form of 2 degrees zirconium alkyls for this metallocene and counterion. The reactivity of 5 with hydrogen is at least 2 orders of magnitude faster than other 1 degrees zirconium alkyls. Such high reactivity accounts for the puzzlingly high fraction of butyl end groups in prior hydrooligomerization studies and implies that catalyst responsivity to H2 as a molecular weight control agent correlates with the regioselectivity of the catalyst.
No takes yet. Share an insight, caveat, or question.
Landis et al. (2004) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: